Reuters logo
BRIEF-CTI Biopharma announces removal of full clinical hold on Pacritinib
January 5, 2017 / 6:39 AM / 10 months ago

BRIEF-CTI Biopharma announces removal of full clinical hold on Pacritinib

Jan 5 (Reuters) - Cti Biopharma Corp

* Announces removal of full clinical hold on Pacritinib

* Response submission included final clinical study reports for PERSIST-1,2 trials; dose-exploration clinical trial protocol FDA requested

* Expects to start trial in Q2 of 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below